Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Smith K < Smith L < Smith M

L. Smith
NONE
000753
Neurodegenerative Diseases Research Centre, Pharmacology Group, Biomedical Sciences Division, King's College London
000753
Lance A. Smith
Division of Pharmacology & Therapeutics, Guy's, King's and St. Thomas’ School of Biomedical Sciences, London, United Kingdom
000016
Division of Pharmacology and Therapeutics, Guy's, King's, and St Thomas' School of Biomedical Sciences, King's College, London, United Kingdom
000262
NONE
000000
000016
000126
000262
000662
000B51
000F44
002934
004334
Neurodegenerative Disease Research Centre, Guy's, King's and St. Thomas' School of Biomedical Sciences, King's College, London, United Kingdom
000F44
Neurodegenerative Disease Research Centre, Guy's, King's, and St. Thomas's School of Biomedical Sciences, King's College London, Guy's Campus, London, U.K.
000126
Neurodegenerative Diseases Research Centre, GKT School of Biomedical Sciences, King's College, London, United Kingdom
000662
004334
Neurodegenerative Diseases Research Centre, Guy's, King's and St. Thomas' School of Biomedical Sciences, King's College, London, United Kingdom
000000
Neurodegenerative Diseases Research Centre, King's College London, United Kingdom
002934
Neurodegenerative Diseases Research Centre, Pharmacology Group, Biomedical Sciences Division, King's College, London, England; Orion‐Farmos
000B51
Lance Smith
NONE
000463
001C15
Neurodegenerative Diseases Research Centre, King's College, London, United Kingdom
001C15
Neurodegenerative Diseases Research Centre, Pharmacology Group, Biomedical Sciences Division, King's College, London, England
000463
Leonard A. Smith
Division of Toxinology and Aerobiology, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA
002B25
NONE
002B25

<g>
<k>Smith L</k>
<l>
<g>
<k>L. Smith</k>
<l>
<g>
<k>
<mods:affiliation>NONE</mods:affiliation>
</k>
<l>
<i>000753</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>Neurodegenerative Diseases Research Centre, Pharmacology Group, Biomedical Sciences Division, King's College London</mods:affiliation>
</k>
<l>
<i>000753</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>2</n>
<t>2</t>
</g>
<g>
<k>Lance A. Smith</k>
<l>
<g>
<k>
<mods:affiliation>Division of Pharmacology & Therapeutics, Guy's, King's and St. Thomas’ School of Biomedical Sciences, London, United Kingdom</mods:affiliation>
</k>
<l>
<i>000016</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>Division of Pharmacology and Therapeutics, Guy's, King's, and St Thomas' School of Biomedical Sciences, King's College, London, United Kingdom</mods:affiliation>
</k>
<l>
<i>000262</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>NONE</mods:affiliation>
</k>
<l>
<i>000000</i>
<i>000016</i>
<i>000126</i>
<i>000262</i>
<i>000662</i>
<i>000B51</i>
<i>000F44</i>
<i>002934</i>
<i>004334</i>
</l>
<n>9</n>
<t>9</t>
</g>
<g>
<k>
<mods:affiliation>Neurodegenerative Disease Research Centre, Guy's, King's and St. Thomas' School of Biomedical Sciences, King's College, London, United Kingdom</mods:affiliation>
</k>
<l>
<i>000F44</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>Neurodegenerative Disease Research Centre, Guy's, King's, and St. Thomas's School of Biomedical Sciences, King's College London, Guy's Campus, London, U.K.</mods:affiliation>
</k>
<l>
<i>000126</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>Neurodegenerative Diseases Research Centre, GKT School of Biomedical Sciences, King's College, London, United Kingdom</mods:affiliation>
</k>
<l>
<i>000662</i>
<i>004334</i>
</l>
<n>2</n>
<t>2</t>
</g>
<g>
<k>
<mods:affiliation>Neurodegenerative Diseases Research Centre, Guy's, King's and St. Thomas' School of Biomedical Sciences, King's College, London, United Kingdom</mods:affiliation>
</k>
<l>
<i>000000</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>Neurodegenerative Diseases Research Centre, King's College London, United Kingdom</mods:affiliation>
</k>
<l>
<i>002934</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>Neurodegenerative Diseases Research Centre, Pharmacology Group, Biomedical Sciences Division, King's College, London, England; Orion‐Farmos</mods:affiliation>
</k>
<l>
<i>000B51</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>9</n>
<t>18</t>
</g>
<g>
<k>Lance Smith</k>
<l>
<g>
<k>
<mods:affiliation>NONE</mods:affiliation>
</k>
<l>
<i>000463</i>
<i>001C15</i>
</l>
<n>2</n>
<t>2</t>
</g>
<g>
<k>
<mods:affiliation>Neurodegenerative Diseases Research Centre, King's College, London, United Kingdom</mods:affiliation>
</k>
<l>
<i>001C15</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>Neurodegenerative Diseases Research Centre, Pharmacology Group, Biomedical Sciences Division, King's College, London, England</mods:affiliation>
</k>
<l>
<i>000463</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>3</n>
<t>4</t>
</g>
<g>
<k>Leonard A. Smith</k>
<l>
<g>
<k>
<mods:affiliation>Division of Toxinology and Aerobiology, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA</mods:affiliation>
</k>
<l>
<i>002B25</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>NONE</mods:affiliation>
</k>
<l>
<i>002B25</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>2</n>
<t>2</t>
</g>
</l>
<n>4</n>
<t>26</t>
</g>

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024